Efinaconazole from Procos

Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry.

Produced in:

Italy

MOQ: -

  • CoA

  • GMP

  • USDMF

Procos Efinaconazole API Producer - 164650-44-6

Description:
Procos offers high-quality Efinaconazole API, certified for compliance with international standards. Manufactured in Italy.

Product Details

Certifications
CoA, GMP, USDMF compliant
Minimum Order Quantity
Produced in
Italy (Europe)
DrugBank ID
DB09040
CAS Number
164650-44-6
Unique Ingredient Identifier
J82SB7FXWB
Raw Material Category
Antimycotics

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Quality Assurance

Procos has successfully passed audits conducted by Eurofins, with reports available that underscore the company's commitment to quality and transparency.

Additional Products

We offer 21 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Efinaconazole API? Contact Procos by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Efinaconazole API

Procos


Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry.